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There is a distinct lack of uniformity in the definitions and clinical terminologies related to oral leukoplakia and 
leukoplakialike lesions and disorders. Proposals have been put forward to subclassify leukoplakia into a homo-
geneous and a non-homogeneous type based on color only, being either predominantly white or mixed white-
and-red, respectively, irrespective of the texture of the lesion. In this proposal there is no need anymore to regard 
the poorly defined proliferative verrucous leukoplakia as a separate entity. Since keratosis is primarily a histo-
pathological term, its clinical use is discouraged. Alternative terminology for these so-called keratotic lesions and 
disorders has been put forward. Finally, a suggestion has been made to rename the term hairy leukoplakia, being 
a well defined, not potentially malignant disorder particularly related to HIV-infection, into ‘EBV-positive white 
lesion of the tongue’ (EBVposWLT).
 




Most, if not all oral squamous cell carcinomas are pre-
ceded by clinically visible changes of the oral mucosa. 
Such changes are often predominantly white, being des-
ignated as leukoplakias. At present, oral leukoplakia has 
been defined as “A predominantly white plaque of ques-
tionable risk having excluded (other) known diseases or 
disorders that carry no increased risk for cancer” (1). It 
has been added that leukoplakia is primarily a clinical 
term and has no specific histology. 
There are many, statistically somewhat useful, predic-
tive factors of malignant transformation. These factors 
include a.o. the clinical subtype (homogeneous versus 
non-homogeneous), the size of the lesion, the oral sub-
site, and the histopathological presence or absence of 
epithelial dysplasia. However, these predictive factors 
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Table 1: Proposal for modified criteria of homogeneous and non-
homogeneous leukoplakia.
are not reliable for use in the individual patient. This 
also applies to the histopathological findings and the 
various molecular markers that have been reported in 
the past decades as predictive markers of malignant 
transformation (2). 
At present, there is a confusing use of clinical terminol-
ogies related to oral leukoplakia. Therefore, proposals 
will be put forward for simplification and consistency 
of these terminologies.
Clinical classification and terminology 
- Homogeneous and non-homogeneous leukoplakia
1. Present classification and terminology
The term homogeneous leukoplakia is by some applied 
for leukoplakias that are thin and flat  (1), while others 
also recognize a thick type of homogeneous leukoplakia 
(3). In addition, various subvariants of homogeneous 
leukoplakia have been described, such as velvetlike 
type and pumice-stone type.
Non-homogeneous leukoplakia has traditionally been 
subdivided into a mixed red-and-white type (erythro-
leukoplakia), being often subdivided  into a speckled, 
granular or nodular type. Verrucous leukoplakia has 
also been classified as a subtype of non-homogeneous 
leukoplakia (4).
In the past decades a separate, third, clinical subtype, 
not specifically being categorized as either homoge-
neous or non-homogeneous leukoplakia,  has been in-
troduced in the literature, being referred to as prolif-
erative verrucous leukoplakia (PVL) (5). Proliferative 
verrucous leukoplakia  has remained a source of confu-
sion since its first description, due to the lack of a proper 
definition (6,7). 
2 Proposed classification and terminology
It may be useful to define homogeneous primarily based 
on a predominantly white color, irrespective of the tex-
ture and irrespective of the extent of the disease. As a 
result one may recognize a thin, thick and verrucous 
subtype of homogeneous leukoplakia, if of relevance at 
all (Fig. 1, Fig. 2, Fig. 3).
Since large, widespread leukoplakias, not necessarily 
PVLs, carry a distinct risk of malignant transformation 
(8), there is no need to classify PVL as a separate entity. 
Being usually predominantly white, PVL can thus be 
classified as a homogeneous leukoplakia (Table 1).
Fig. 1: Homogeneous leukoplakia (thin, flat type).
Fig. 2: Homogeneous leukoplakia (thick or verrucous type).
Fig. 3: Homogeneous leukoplakia (thick or verrucous type).
Present criteria Proposed criteria
Homogeneous leukoplakia, 
predominantly white                  
- thin, flat
Homogeneous leukoplakia, 
predominantly white               
- thin, flat, thick, verrucous 
(including proliferative 
verrucous leukoplakia, if 
there remains a need at all 
for this terminology)
Non-homogeneous leukoplakia 
- mixed white-and-red appea-
rance (erythroleukoplakia), 





- mixed white-and-red 
appearance (erythroleuko-
plakia), includes nodular, 
speckled, granular
Note: proliferative verrucous leukoplakia (PVL) has never 
been clearly categorized as either homogeneous or non-ho-
mogeneous leukoplakia             
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In fact, the use of the term PVL should be discouraged.
Non-homogeneous leukoplakia is primarily based on 
a mixed white-and-red appearance, irrespective of the 
texture (Fig. 4).
2. Sublingual keratosis refers to widespread whitish 
changes of the floor of the mouth, the ventral aspect of 
the tongue and the lingual mucosa. Apparently, sublin-
gual keratosis carries a high risk of malignant transfor-
mation (10). 
3. A few papers have been published on alveolar ridge 
keratosis (11,12). Apparently, the lesion is caused by 
chronic frictional (masticatory) trauma to the maxillary 
and mandibular alveolar ridges, particularly in the ret-
romolar pad and edentulous parts of the alveolar ridges. 
Histopathologically, almost all of these lesions show 
hyperkeratosis without epithelial dysplasia. The authors 
suggested to remove this lesion from the category of 
oral leukoplakia because of its low risk of malignant 
transformation. 
4. The term frictional keratosis has been used for white 
lesions on the facial attached gingiva that are suppos-
edly caused by friction, ie. vigorously brushing of the 
teeth or masticatory function (13).  The authors suggest-
ed to remove this lesion from the category of leukopla-
kia because of its low risk of malignant transformation.
5. In sanguinaria-associated keratosis the white changes 
of the oral mucosa, particularly located in the buccal 
aspect of the maxilla or the maxillary vestibule, are 
ascribed to sanguinaria, a herbal extract used in den-
tifrices and mouthrinses (14). In some cases epithelial 
dysplasia was observed. 
6. In tobacco pouch keratosis, also referred to as snuff 
dipper’s lesion, the clinical aspect may vary from a 
white to a more greyish aspect of the oral mucosa in di-
rect contact with the tobacco product. Epithelial dyspla-
sia is rarely encountered. The risk of malignant trans-
formation seems to be mainly related to the type of the 
chewing product (15).
7. The term keratosis of unknown significance (KUS) is 
a histopathological diagnosis and is not used as a clini-
cal term (16).
- Proposed classification and terminology
The use of keratosis as a clinical term is not quite ap-
propriate. Keratosis is primarily a histopathological 
term that is used to describe hyperorthokeratosis or 
hyperparakeratosis. In addition, it has been shown that 
thickening of the keratin layer of the epithelium may 
not always be the primary factor in causing an intraoral 
lesion to appear white (17). Another reason to abandon 
keratosis as a clinical term is its likely perception by 
clinicians of being a benign lesion, while some of these 
lesions do have malignant potential.
1. The term reversed smoking associated keratosis could 
perhaps be renamed as reversed smoking associated 
(erythro)leukoplakia, but is seems better to abandon the 
term and to list reversed smoking under the umbrella of 
tobacco habits as a possible cause of leukoplakia.
2. The term sublingual keratosis actually represents 
an extensive leukoplakia of the floor of the mouth and, 
Fig. 4: Non-homogeneous leukoplakia (‘Erythroleukoplakia’).
At the other end of the spectrum one recognizes eryth-
roplakia, being predominantly red, irrespective of the 
texture of the lesion (Fig. 5).
Fig. 5: Erythroleukoplakia.
When a biopsy has been taken, one may or may not en-
counter epithelial dysplasia, resulting in a terminology of 
dysplastic and a non-dysplastic leukoplakia. In case of car-
cinoma in situ, squamous cell carcinoma and verrucous 
carcinoma, the term leukoplakia is replaced accordingly.
Keratoses
- Present classification and terminology
The term keratosis is probably quite commonly used, 
particularly by clinicians, to describe an oral white le-
sion that is otherwise not recognized as a known entity. 
1. The term reversed smoking keratosis is used to de-
scribe initially white changes of the palatal mucosa due 
to the habit of reversed smoking. These palatal lesions 
carry a high risk of malignant transformation (9). 
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at present, there is no reason to typify leukoplakias by 
their oral subsite. Therefore, this terminology can be 
abandoned. 
3. Although leukoplakias of the maxillary and mandib-
ular alveolar ridges may carry a lower risk of malig-
nant transformation compared with leukoplakias of the 
tongue or the floor of the mouth, it does not seem justi-
fied to designate alveolar ridge keratosis as a benign le-
sion and to remove this lesion from the category of oral 
leukoplakia. As in sublingual keratosis, there is at pres-
ent no reason to classify leukoplakias by their oral sub-
site.  Altogether, this terminology can be abandoned.
4. For reasons mentioned before, the term frictional ker-
atosis might be changed into frictional lesion, but only 
as a provisional clinical term. When the lesion does not 
regress after elimination of the friction there is no jus-
tification anymore for its use and in such cases a diag-
nosis of leukoplakia seems preferable. There seems no 
need to add that the leukoplakia is located at the facial 
attached gingiva.
5. The use of the term sanguinaria-associated kerato-
sis is actually based on one study of ten patients. No 
follow-up data were available. Therefore, the proof of 
sanguinaria as being the causative factor is more or less 
lacking. Altogether the use of the term sanguinaria-as-
sociated keratosis can perhaps be abandoned. Sangui-
naria might be included in the list of possible etiological 
factors of leukoplakia. 
6. The terms tobacco pouch keratosis and snuff dipper’s 
lesion, can perhaps be abandonned. The role of smoke-
less tobacco could be specifically mentioned in the list 
of tobacco habits as an etiologic factor of leukoplakia.
7. Since the term keratosis of unknown significance 
(KUS) is a histopathological diagnosis there is no rea-
son for any modification. 
All the above is summarized in Table 2. 
Hairy leukoplakia
-  Present terminology
Hairy leukoplakia (HL) represents a benign whit-
ish change of the mucosa of the borders of the tongue 
that mainly occurs in HIV infected patients. Neverthe-
less, HL may also occur as a side-effect of prolonged 
use of immunosuppressive drugs, e.g. after solid organ 
transplantation. HL rarely occurs in immunocompetent 
patients (18). The immunohistochemical presence of 
Epstein Barr virus (EBV) in superficial koilocytic epi-
thelial cells is required for a final diagnosis of HL.
- Proposed terminology
The term ‘hairy leukoplakia’ is not appropriate for two 
reasons, being 1) it is a well defined, known, entity and, 
therefore does not comply with the definition of leuko-
plakia, and 2) it is not a potentially malignant disorder. 
Admittedly, it is difficult to come up with a better term. 
One might think of ‘EBV-positive white lesion of the 
tongue’ (EBVposWLT). 
Discussion and conclusions
The present definition of leukoplakia is not much dif-
ferent from the ones published in 1978 and 1996 (4,19). 
Unfortunately, the definition is still worded in a nega-
tive way by exclusion of other white lesions. 
In the present proposed classification of homogeneous 
and non-homogeneous leukoplakia, primarily based 
on color, irrespective of the texture of the lesion, the 
question may arise on how much redness is required for 
classifying a mucosal lesion as non-homogeneous leu-
koplakia/erythroleukoplakia instead of homogeneous 
leukoplakia. Likewise, one may ask how much redness 
is required for classifying a lesion as an erythroplakia 
instead of an erythroleukoplakia. Admittedly, such 
questions can at present not be solved in an objective, 
reproducible manner, being just based on subjective, 
clinical judgment. Application of artificial intelligence 
Present terminology Proposed terminology
General remark:
The use of ‘keratosis’ as a clinical term is discouraged
Reversed smoking keratosis Can be categorized as leukoplakia or erythroleukoplakia; reversed smoking can be listed under the 
umbrella of the various tobacco habits 
Sublingual keratosis Can be categorized as leukoplakia; there is no need to subclassify leukoplakia by oral subsite
Alveolar ridge keratosis Can be categorized as leukoplakia; there is no need to subclassify leukoplakia by oral subsite
Frictional keratosis The term frictional lesion could be applied, only in retrospect, to a white lesion that has disappea-
red after elimination of the friction. If the lesion persists, it should be called  leukoplakia
Sanguinaria-associated keratosis The term sanguinaria-associated lesion could be applied, only in retrospect, to a white lesion that 
has disappeared after elimination of the sanguinaria component. If the lesion persists, it should be 
called leukoplakia
Tobacco pouch keratosis (snuff 
dippers’s lesion)
Can be replaced by leukoplakia; the snuff dipping habit can be mentioned in the list of the various 
tobacco habits
Keratosis of unknown significance Since this is a histopathological term and not a clinical one, there is no need for modification
Table 2: Proposal for modified terminologies of so-called keratoses.
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on standardized photographs may perhaps overcome 
this shortcoming. Furthermore, one may question the 
relevance of the morphological subtyping of oral leu-
koplakias. The extent of the leukoplakia may, indeed, 
be much more important in the prediction of malignant 
transformation than its morphology (8).
It is well realized that the figures that have been used in 
this treatise are an extreme simplification of the wide 
range of clinical morphologies of leukoplakia that one 
encounters in the daily practice.
Proper communication between clinicians and patholo-
gists is important, particularly in the field of oral poten-
tially malignant disorders. For instance, some patholo-
gists will deny a diagnosis of leukoplakia in the absence 
of epithelial dysplasia. 
The clinical use of keratosis is discouraged. Further-
more, the use of strict diagnostic criteria is recommend-
ed for lesions or diseases for which a possible caus-
ative factor has been identified, e.g. frictional lesion. A 
somewhat arbitrarily chosen period of 4-8 weeks after 
removal of the possible cause should be taken into ac-
count, being a practical and safe time period, to await 
the disappearance of such lesion.  If unchanged, a di-
agnosis of leukoplakia prevails. Additional descriptions 
such as friction associated, tobacco associated leuko-
plakia or sanguinaria associated leukoplakia do not 
seem to be of much relevance, if any.
The term ‘hairy leukoplakia’ is rather unfortunate and 
may be replaced by ‘EBV-positive white lesion of the 
tongue’ (EBVposWLT). Such an extensive nomen-
clature will perhaps not easily be accepted, but seems 
more appropriate than the term hairy leukoplakia.
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